CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 03/31/2014

Position Statistics

Total Positions 58
New Positions 20
Increased Positions 34
Decreased Positions 18
Positions with Activity 52
Sold Out Positions 11
Total Mkt Value (in $ millions) 472

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 5.18%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 83.22%
Services
Technology
Transportation
Utilities

58 Positions as of 03/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
OMEROS CORP COM 7,175 7,175 New 500,000
CHIMERIX INC COM 6,861 3,591 109.79 300,000
PROTHENA CORP PLC SHS 6,633 6,633 New 350,000
ACADIA PHARMACEUTICALS COM 6,219 -10,365 (62.5) 300,000
EAGLE PHARMACEUTICALS INC COM 5,044 5,044 New 400,000
NANOSTRING TECHNOLOGIES INC COM 5,020 5,020 New 400,000
PORTOLA PHARMACEUTICALS INC COM 4,984 3,115 166.67 200,000
GALECTIN THERAPEUTICS INC COM NEW 4,691 4,691 New 348,000
NOVAVAX INC COM 4,540 New 1,000,000
CLOVIS ONCOLOGY INC COM 4,422 26 .59 120,000
PACIRA PHARMACEUTICALS INC COM 4,326 New 50,000
ROCKWELL MED INC COM 4,176 4,176 New 400,000
GLYCOMIMETICS INC COM 4,027 4,027 New 469,400
GERON CORP COM 3,795 -4,800 (55.85) 1,500,000
SORRENTO THERAPEUTICS INC COM NEW 3,745 3,745 New 700,000
BIOGEN IDEC INC COM 3,376 3,376 New 10,000
AGENUS INC COM NEW 3,050 3,050 New 1,000,000
GENVEC INC COM NEW 2,938 2,938 New 1,329,300
RECRO PHARMA INC COM 2,925 2,925 New 500,000
ALNYLAM PHARMACEUTICALS INC COM 2,793 -11,172 (80) 50,000